Company Overview
Snapshot
Founded in April 2010 by Nini Bluman and Haim Hoffman, BioXtreme operates with 11–50 employees. The company has raised $5.67M across 4 funding rounds from 5 investors. In March 2024, BioXtreme secured a grant from the Israel Innovation Authority.
Business overview
BioXtreme develops robotic systems for patient rehabilitation following strokes, traumatic brain injuries, and other neurological disorders. Its core technology integrates biofeedback and 3D virtual reality into real-life environments, utilizing precise measurements of muscle strength and range of motion to apply forces with high accuracy. Key products include DeXtreme, which incorporates biofeedback and VR, and plaXtreme, designed to restore palm and finger motor skills. The company serves the healthcare industry, specifically targeting healthcare providers and insurance companies, and operates within the Health Tech & Life Sciences sector, focusing on medical devices and digital therapeutics.
Strategic signal
In June 2022, BioXtreme was highlighted in an article discussing its impact on the field of stroke rehabilitation. This signals the company's growing recognition and potential to significantly advance treatment methodologies for neurological conditions, attracting attention from healthcare professionals and investors interested in innovative medical technologies.
Log in to access full profile ›Company Intelligence Q&A
- What is BioXtreme's primary focus?
- BioXtreme specializes in developing robotics systems to assist in patient rehabilitation from strokes, traumatic brain injuries, and other neurological disorders.
- When was BioXtreme founded?
- BioXtreme was founded in April 2010 by Nini Bluman and Haim Hoffman.
- What is the DeXtreme system?
- The DeXtreme system integrates biofeedback and 3D virtual reality into real-life environments, using precise measurements to apply forces with high accuracy across the entire motion cycle for rehabilitation.
- What is plaXtreme designed for?
- plaXtreme is an advanced robotic device designed to restore palm and finger motor skills in individuals who have experienced stroke, traumatic brain injuries, and other neurological conditions.
- Has BioXtreme received any grants?
- In March 2024, BioXtreme secured a grant from the Israel Innovation Authority.